Marketing research of the pharmaceutical market of drugs for treating varicose veins and inflammatory diseases of joints
Keywords:venous disease, drug combinations, extract, marketing, market analysis.
According to the data of the International Union of Phlebologists venous pathologies in various forms occur in 60-75% of the population. InEurope, the lower limb varicosity is observed in 25-33% of women and 10-20% of men; it allows to reliably refer the varicose disease to “diseases of civilization”. When introducing a new medicine the marketing calculations are of particular importance taking into account the competitiveness of the product at the domestic market.
Aim. To perform the marketing analysis of the wholesale market of drugs used in the treatment of varicose veins and inflammatory diseases of the joints.
Materials and methods. The assortment of drugs was analyzed in accordance with the State Registry of Medicines of Ukraine and the ATC classification. The pharmaceutical market of the following drugs was studied: group M02AX – other remedies applied locally for joint and muscular pain, C05VA – heparin or heparinoids for local application and C05CX – other capillary stabilizing agents.
Results. Based on results of our studies it can be stated that the market of drugs under research is characterized by a favorable environment for consumers in terms of a large number of interchangeable drugs. It should be noted that the local market of drugs with the antivaricose activity is widely represented by synthetic drugs that have side effects, including allergic reactions to substances. Therefore, application of the combined herbal medicinal products is increasingly rational.Conclusions. The analysis by medicinal forms among the drugs used in joint and muscle pain has revealed that soft dosage forms are the leaders (54.6 % of the total number of drugs). The analysis by the pack size of antivaricose medicines has determined that all drugs in the group are presented only in soft dosage forms, namely gels (75 %), ointments (16.67 %) and creams (8.33 %). The analysis of the pack size of capillary stabilizing drugs has shown that solid dosage forms prevail in the group, namely tablets, granules and capsules (43.25%).
Kamins’ka, O. L., Kukhtenko, O. S. (2014). Proceeding of Tekhnolohichni ta biofarmatsevtychni aspekty stvorennya likars’kykh preparativ riznoyi napravlenosti diyi : materialy I naukovo-praktichnoi Internet-konferentsii [Technological and biopharmaceutical aspects of the creation of medicinal preparations of different direction of action]. (p. 83). Kharkiv.
Evropeiska baza danyh statystychnoi informatsii “Zdorov’ia dlia vsih” [The European statistic information database «Health for All»]. Retrieved from: http://medstat.gov.ua/ukr/normdoc.html.
Derzhavnyi reestr likarskykh zasobiv Ukrainy [State register of medicinesUkraine]. Retrieved from: http://www.drlz.kiev.ua/.
Compendium. Retrieved from: http://compendium.com.ua/.
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).